| Daniel R Farber, MD | |
|
2629 N 7th St, Sheboygan, WI 53083 | |
| (920) 451-5000 | |
| Not Available |
| Full Name | Daniel R Farber |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 13 Years |
| Location | 2629 N 7th St, Sheboygan, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356639553 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 59046 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Sheboygan Memorial Medical Ctr | Sheboygan, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
The saturated European market for infant care solutions has received fresh impetus from the rising incidence of preterm births. This trend is not only fuelling the demand for neonatal intensive care unit (NICU) devices but also skilled and trained professionals to operate these devices.
The Washington Post examines how African countries are "grappling with debates over what rights and duties to give those living with [HIV/AIDS] - a growing segment of the population that remains largely hidden." The newspaper writes: "Across the continent, lawmakers are considering whether to make criminals of those who infect others with HIV, allow bosses to test workers for the virus, punish women who pass it to their babies and give constitutional protections to those with HIV."
TriLink BioTechnologies, Inc., a leader in manufacturing high quality oligonucleotides and nucleoside triphosphates, announced today the award of their CleanAmp Primer patent by the European Patent Office (EPO Patent no. 2032714).
A new firearms research database launched by the Harvard School of Public Health makes scholarly articles more accessible to reporters, law enforcement, public health officials, policymakers, and the general public.
ev3 Inc., a global endovascular device company, today announced that it has filed the final module of its Premarket Approval application with the U.S. Food and Drug Administration for the Pipeline Embolization Device. This final module, containing a comprehensive review of the clinical data, completes the PMA application to the FDA.
› Verified 9 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
The saturated European market for infant care solutions has received fresh impetus from the rising incidence of preterm births. This trend is not only fuelling the demand for neonatal intensive care unit (NICU) devices but also skilled and trained professionals to operate these devices.
The Washington Post examines how African countries are "grappling with debates over what rights and duties to give those living with [HIV/AIDS] - a growing segment of the population that remains largely hidden." The newspaper writes: "Across the continent, lawmakers are considering whether to make criminals of those who infect others with HIV, allow bosses to test workers for the virus, punish women who pass it to their babies and give constitutional protections to those with HIV."
TriLink BioTechnologies, Inc., a leader in manufacturing high quality oligonucleotides and nucleoside triphosphates, announced today the award of their CleanAmp Primer patent by the European Patent Office (EPO Patent no. 2032714).
A new firearms research database launched by the Harvard School of Public Health makes scholarly articles more accessible to reporters, law enforcement, public health officials, policymakers, and the general public.
ev3 Inc., a global endovascular device company, today announced that it has filed the final module of its Premarket Approval application with the U.S. Food and Drug Administration for the Pipeline Embolization Device. This final module, containing a comprehensive review of the clinical data, completes the PMA application to the FDA.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel R Farber, MD 2629 N 7th St, Sheboygan, WI 53083-4932 Ph: (920) 451-5000 | Daniel R Farber, MD 2629 N 7th St, Sheboygan, WI 53083 Ph: (920) 451-5000 |
News Archive
The saturated European market for infant care solutions has received fresh impetus from the rising incidence of preterm births. This trend is not only fuelling the demand for neonatal intensive care unit (NICU) devices but also skilled and trained professionals to operate these devices.
The Washington Post examines how African countries are "grappling with debates over what rights and duties to give those living with [HIV/AIDS] - a growing segment of the population that remains largely hidden." The newspaper writes: "Across the continent, lawmakers are considering whether to make criminals of those who infect others with HIV, allow bosses to test workers for the virus, punish women who pass it to their babies and give constitutional protections to those with HIV."
TriLink BioTechnologies, Inc., a leader in manufacturing high quality oligonucleotides and nucleoside triphosphates, announced today the award of their CleanAmp Primer patent by the European Patent Office (EPO Patent no. 2032714).
A new firearms research database launched by the Harvard School of Public Health makes scholarly articles more accessible to reporters, law enforcement, public health officials, policymakers, and the general public.
ev3 Inc., a global endovascular device company, today announced that it has filed the final module of its Premarket Approval application with the U.S. Food and Drug Administration for the Pipeline Embolization Device. This final module, containing a comprehensive review of the clinical data, completes the PMA application to the FDA.
› Verified 9 days ago
Dr. Raymond Seth Sohn, D.O Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2124 Kohler Memorial Dr Ste 110, Sheboygan, WI 53081 Phone: 920-204-6758 Fax: 888-720-0495 | |
Dr. Bryan Stuart Wichman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3100 Superior Ave, Sheboygan, WI 53081 Phone: 920-783-1261 | |
Samuel D. Parks, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3100 Superior Ave, Sheboygan, WI 53081 Phone: 608-263-8114 | |
Dr. Joseph S Bernstein, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3100 Superior Ave, Sheboygan, WI 53081 Phone: 920-459-4700 | |
Dr. Joshua R Lacey, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2629 N 7th St, Sheboygan, WI 53083 Phone: 920-451-5000 | |
Dr. James S Hoell, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2629 N 7th St, Sheboygan, WI 53083 Phone: 920-451-5000 Fax: 920-451-5143 |